SKN | Kiniksa Pharmaceuticals International, plc (KNSA) — Biotech Growth Story Faces Market Scrutiny as IPO Appetite for Drug Developers Tightens
Lead Paragraph
Kiniksa Pharmaceuticals International, plc (KNSA) is advancing in a public-market process that underscores both the resilience and selectivity of biotech IPO activity. The...
SKN | Collective Acquisition Corp. II Units: Blank Check Vehicle Returns as SPAC Market Tests Investor Depth
Collective Acquisition Corp. II is moving forward with a units-based IPO structure targeting approximately $8 million US in gross proceeds, as the special purpose...
SKN | Sanmina Jumps After Earnings as Electronics Manufacturing Demand Strengthens
Sanmina Corporation surged 14.56% to close at $215.46, with continued gains in after-hours trading pushing the stock above $216. The move marks a sharp...
SKN | AsiaFIN Expands IPO Strategy as Fintech Demand Drives Deal Restructuring
IPO Terms Adjusted to Capture Market Opportunity
AsiaFIN Holdings has revised the structure of its upcoming US initial public offering, increasing its targeted raise to...
SKN | GraniteShares YieldBOOST CRCL ETF: Structured Income Strategy Tests Appetite for Leveraged Yield Products
GraniteShares YieldBOOST CRCL ETF is moving through a capital markets listing process targeting approximately $8 million US in initial assets, as demand grows for...